← 產業報告目錄

Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-05-06頁數 265報告編號 MD6285

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global sleep apnea oral appliances market is projected to reach USD 0.8 billion by 2030 from USD 0.5 billion in 2025, at a CAGR of 9.8% during the forecast period. The market is experiencing growth due to a rise in lifestyle-related disorders such as diabetes, hypertension, and obesity, which can lead to obstructive sleep apnea and make it difficult for patients to breathe. There is also a growing awareness of sleep apnea and its management and treatment options. Furthermore, leading players in the industry are introducing innovative products and expanding their portfolios. These companies offer a variety of advanced, non-invasive oral appliances that are adjustable to meet patients' needs better. By end user, the home care settings/individuals segment is expected to dominate the market during the forecast period. By end users, the sleep apnea appliances market is segmented into clinics, hospitals, and home care settings/individuals. The home care settings/individuals segment accounted for the largest share of the market in 2024. The key factor contributing to market growth in this segment includes the preference of adopting sleep apnea devices in these settings owing to ease of convenience, remote availability, and cost-efficiency compared to hospitalization. These devices are covered by insurance or reimbursement policies. The home care setting is a growing market due to the increasing prevalence of sleep apnea, particularly in developed regions like North America and Europe. This rise is primarily attributed to the lifestyle choices common in these areas. Additionally, the accessibility of home sleep apnea tests is a significant factor contributing to the growth of the sleep apnea oral appliances market. By distribution channel, the retail pharmacies segment accounted for the largest market share in 2024. By distribution channel, the sleep apnea oral appliances market is divided into online pharmacies, retail pharmacies, and hospital pharmacies & dental clinics. Among these, the retail pharmacies segment accounted for the largest market share in 2024 owing to the increasing availability of oral sleep apnea appliances in retail pharmacies and the rising establishment of these settings in emerging markets. There is a growing awareness of the risks associated with undiagnosed sleep apnea, leading to an increased demand for oral appliances. This has resulted in zero waiting times at retail pharmacies, which offer a variety of devices that vary in affordability and quality. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. The global sleep apnea oral appliances market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest-growing regional sleep apnea organ appliance market. The key factors contributing to the high growth rate of the Asia Pacific market are the presence of manufacturing & distribution companies in the region. Some key players have recently expanded their presence in the Asia Pacific by setting up a manufacturing plant for oral appliances. Additionally, advancements in infrastructure and technology in the healthcare sector in the Asia Pacific market are increasing. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–40%, Tier 2–50%, and Tier 3– 10% • By Designation: C-level–48%, Director-level–37% and Others–15% • By Region: North America–46%, Europe–26%, Asia Pacific–15%, Latin America- 6%, the Middle East & Africa – 4%, and GCC Countries – 3% Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The leading players operating in the sleep apnea oral appliances market are SomnoMed (Australia), Resmed (US), ProSomnus Sleep Technologies (US), DynaFlex (US), Vivos Therapeutics, Inc. (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC (US), and Braebon Medical Corporation (Canada). Research Coverage This report studies the sleep apnea oral appliances market based on product, gender, purchase type, age group, distribution channel, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments about five major regions (and the respective countries in these regions). Reasons to Buy the Report The report will help established and new or smaller firms understand the market dynamics, allowing them to capture a larger market share. Companies that purchase the report can implement one or a combination of the strategies mentioned below to strengthen their market presence. This report provides insights on the following pointers: • Analysis of key drivers (Large pool of undiagnosed sleep apnea patients globally, growing awareness about effects of untreated sleep apnea among patients, rising usage of oral appliances among patients with mild-to-moderate sleep apnea, and the increasing number of companies in sleep apnea devices and oral appliances market), restraints (high prices of customized oral appliances, alternative therapies and medications for sleep apnea, risks associated with oral appliance therapy for obstructive sleep apnea), opportunities (growing demand for home sleep apnea tests as cost-saving measures; increasing focus on telemedicine, mhealth, and AI; poor compliance associated with CPAP) and challenges (complex referral pathways and long waiting periods) influencing the growth of the sleep apnea oral appliances market) • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the sleep apnea oral appliances market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the sleep apnea oral appliances market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the sleep apnea oral appliances market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.2.1 INCLUSIONS & EXCLUSIONS 29 1.3 MARKET SCOPE 30 1.3.1 MARKETS COVERED & GEOGRAPHIC SPREAD 30 1.3.2 YEARS CONSIDERED 31 1.3.3 CURRENCY CONSIDERED 31 1.4 MARKET STAKEHOLDERS 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY DATA 33 2.1.1.1 Key data from secondary sources 34 2.1.2 PRIMARY DATA 34 2.1.2.1 Primary sources 35 2.1.2.2 Key industry insights 36 2.1.2.3 Key data from primary sources 36 2.1.2.4 Breakdown of primary interviews 38 2.2 MARKET SIZE ESTIMATION 38 2.2.1 BOTTOM-UP APPROACH 39 2.2.1.1 Approach 1: Company revenue estimation approach 39 2.2.1.2 Approach 2: Presentations of companies and primary interviews 39 2.2.1.3 Approach 3: Primary interviews 40 2.2.1.4 Approach 4: Growth Forecast 40 2.2.1.5 CAGR projections 40 2.2.2 TOP-DOWN APPROACH 41 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 42 2.4 RESEARCH LIMITATIONS 43 2.5 RESEARCH ASSUMPTIONS 43 2.5.1 STUDY-RELATED ASSUMPTIONS 43 2.5.2 GROWTH RATE ASSUMPTIONS 44 2.6 RISK ASSESSMENT 45 3 EXECUTIVE SUMMARY 46   4 PREMIUM INSIGHTS 51 4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW 51 4.2 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030 52 4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2024) 53 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 5.2.1 DRIVERS 55 5.2.1.1 Large pool of undiagnosed sleep apnea patients 55 5.2.1.2 Growing awareness associated with effects of untreated sleep apnea 56 5.2.1.3 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea 57 5.2.1.4 Entry of established companies with advanced sleep apnea oral solutions 58 5.2.2 RESTRAINTS 58 5.2.2.1 High price of customized oral appliances 58 5.2.2.2 Alternative therapies & medications for sleep apnea 59 5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea 59 5.2.3 OPPORTUNITIES 59 5.2.3.1 Rising demand for at-home sleep apnea tests 59 5.2.3.2 Increasing importance of telemedicine, mHealth, and AI 60 5.2.3.3 Poor compliance and low adherence associated with CPAP 61 5.2.4 CHALLENGES 62 5.2.4.1 Complex referral pathways and long waiting periods 62 5.3 PRICING ANALYSIS 62 5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023−2025 62 5.3.2 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023−2025 63 5.3.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023−2025 64 5.4 VALUE CHAIN ANALYSIS 65 5.5 SUPPLY CHAIN ANALYSIS 66 5.6 ECOSYSTEM ANALYSIS 67 5.7 PORTER’S FIVE FORCES ANALYSIS 68 5.7.1 THREAT OF NEW ENTRANTS 69 5.7.2 THREAT OF SUBSTITUTES 69 5.7.3 BARGAINING POWER OF SUPPLIERS 69 5.7.4 BARGAINING POWER OF BUYERS 69 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69 5.8 REGULATORY ANALYSIS 70 5.8.1 REGULATORY LANDSCAPE 70 5.8.1.1 North America 70 5.8.1.1.1 US 70 5.8.1.1.1.1 Reimbursement scenario in US 71 5.8.1.1.2 Canada 72 5.8.1.2 Europe 72 5.8.1.3 Asia Pacific 73 5.8.1.3.1 Japan 73 5.8.1.3.2 China 74 5.8.1.3.3 India 75 5.8.1.3.4 Australia 75 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 5.8.2.1 North America 76 5.8.2.2 Europe 76 5.8.2.3 Asia Pacific 77 5.8.2.4 Latin America 78 5.8.2.5 Middle East & Africa 78 5.9 TRADE ANALYSIS 78 5.9.1 TRADE ANALYSIS FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES 78 5.10 PATENT ANALYSIS 80 5.11 KEY CONFERENCES & EVENTS, 2025−2026 81 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 5.13 KEY STAKEHOLDERS & BUYING CRITERIA 83 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 5.13.2 BUYING CRITERIA 84 5.14 IMPACT OF GENERATIVE AI ON SLEEP APNEA ORAL APPLIANCES MARKET 84 5.14.1 INTRODUCTION 85 5.14.2 MARKET POTENTIAL FOR SLEEP APNEA ORAL APPLIANCES 85 5.14.3 FUTURE OF GENERATIVE AI IN SLEEP APNEA ORAL APPLIANCES MARKET 86 5.15 INVESTMENT & FUNDING SCENARIO 87 5.16 TECHNOLOGY ANALYSIS 87 5.16.1 KEY TECHNOLOGIES 87 5.16.1.1 Mandibular advancement devices 87 5.16.2 ADJACENT TECHNOLOGIES 88 5.16.2.1 Daytime-nighttime appliances 88 5.17 END-USER PERCEPTION ANALYSIS 88 5.18 PURCHASE DECISION-MAKING PROCESS 89 5.18.1 INTRODUCTION 89 5.18.1.1 Need recognition 89 5.18.1.2 Gathering information 90 5.18.1.3 Evaluating alternatives 90 5.19 TRUMP TARIFF IMPACT ON SLEEP APNEA ORAL APPLIANCES MARKET 92 5.19.1 INTRODUCTION 92 5.19.2 KEY TARIFF RATES 93 6 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT 94 6.1 INTRODUCTION 95 6.2 MANDIBULAR ADVANCEMENT DEVICES 96 6.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES 99 6.2.1.1 Low cost of ready-made MADs to boost demand 99 6.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES 101 6.2.2.1 High efficacy of custom-made MADs to support market growth 101 6.3 TONGUE-RETAINING DEVICES 103 6.3.1 LOWER SUCCESS RATE OF TRDS TO HINDER MARKET GROWTH 103 6.4 DAYTIME-NIGHTTIME APPLIANCES 105 6.4.1 INCREASING COMFORT & CONVENIENCE TO FUEL MARKET 105 7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE 106 7.1 INTRODUCTION 107 7.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES 107 7.2.1 FAILURE ASSOCIATED WITH CPAP THERAPY TO BOOST DEMAND 107 7.3 ONLINE OTC ORAL APPLIANCES 110 7.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH 110 8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER 112 8.1 INTRODUCTION 113 8.2 MALE PATIENTS 114 8.2.1 INHERENT DIFFERENCES IN BODY ANATOMY TO FUEL UPTAKE 114 8.3 FEMALE PATIENTS 115 8.3.1 GROWING AWARENESS FOR IMPROVED DIAGNOSIS TO SUPPORT MARKET 115 9 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP 118 9.1 INTRODUCTION 119 9.2 BELOW 40 YEARS 120 9.2.1 LOWER PREVALENCE OF OSA IN YOUNGER AGE GROUPS TO RESTRAIN MARKET 120 9.3 BETWEEN 40–60 YEARS 121 9.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH 121 9.4 ABOVE 60 YEARS 123 9.4.1 AGE-ASSOCIATED DISORDERS TO SUPPORT MARKET GROWTH 123   10 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL 126 10.1 INTRODUCTION 127 10.2 ONLINE PHARMACIES 127 10.2.1 RISING BENEFITS OFFERED BY E-COMMERCE TO PROPEL MARKET 127 10.3 RETAIL PHARMACIES 129 10.3.1 RISING ACCESSIBILITY TO WIDE RANGE OF ORAL APPLIANCES TO BOOST DEMAND 129 10.4 HOSPITAL PHARMACIES & DENTAL CLINICS 131 10.4.1 PROVISION OF MAD AND TRD DEVICES DURING ORAL PROCEDURES TO SUPPORT MARKET GROWTH 131 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER 134 11.1 INTRODUCTION 135 11.2 HOME CARE SETTINGS/INDIVIDUALS 135 11.2.1 GROWING PATIENT PREFERENCE FOR REMOTE OSA SERVICES TO PROPEL MARKET 135 11.3 HOSPITALS 137 11.3.1 ABILITY TO PURCHASE ADVANCED SLEEP APNEA EQUIPMENT TO DRIVE MARKET 137 11.4 DENTAL CLINICS 140 11.4.1 INCREASING ESTABLISHMENT OF PRIVATE DENTAL PRACTICES TO SUPPORT MARKET GROWTH 140 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION 142 12.1 INTRODUCTION 143 12.2 NORTH AMERICA 143 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144 12.2.2 US 148 12.2.2.1 Favorable reimbursements and regulatory support to fuel market 148 12.2.3 CANADA 152 12.2.3.1 Increasing number of research grants for awareness of sleep disorders to drive market 152 12.3 EUROPE 155 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 156 12.3.2 GERMANY 159 12.3.2.1 High prevalence of smokers and favorable health insurance coverage to fuel market 159 12.3.3 UK 162 12.3.3.1 Rising awareness among patients and increasing number of sleep service groups to support market 162 12.3.4 FRANCE 165 12.3.4.1 Expanding geriatric population and growing awareness of early diagnosis for OSA to drive market 165 12.3.5 ITALY 168 12.3.5.1 High prevalence of obesity and CVD to fuel market 168 12.3.6 SPAIN 171 12.3.6.1 Growing focus on telemedicine and remote monitoring of OSA patients to drive market 171 12.3.7 REST OF EUROPE 174 12.4 ASIA PACIFIC 177 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 177 12.4.2 CHINA 181 12.4.2.1 Rising geriatric population and increasing cases of obesity to boost demand 181 12.4.3 JAPAN 184 12.4.3.1 Rising demand for cloud-connected sleep apnea therapeutic devices to fuel uptake 184 12.4.4 AUSTRALIA 187 12.4.4.1 Launch of technologically advanced OSA devices to aid market growth 187 12.4.5 REST OF ASIA PACIFIC 190 12.5 LATIN AMERICA 193 12.5.1 POOR HEALTHCARE INFRASTRUCTURE AND LIMITED PUBLIC HEALTH INITIATIVES TO RESTRAIN MARKET 193 12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 194 12.6 MIDDLE EAST & AFRICA 197 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 197 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 197 12.7 GCC COUNTRIES 200 12.7.1 HIGH OBESITY RATE AMONG WOMEN TO SUPPORT MARKET GROWTH 200 12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 201 13 COMPETITIVE LANDSCAPE 204 13.1 OVERVIEW 204 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 204 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET 204 13.3 REVENUE ANALYSIS, 2022–2024 207 13.4 MARKET SHARE ANALYSIS, 2024 208 13.4.1 RANKING OF KEY MARKET PLAYERS 209 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 210 13.5.1 STARS 210 13.5.2 EMERGING LEADERS 210 13.5.3 PERVASIVE PLAYERS 210 13.5.4 PARTICIPANTS 210 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 212 13.5.5.1 Company footprint 212 13.5.5.2 Region footprint 213 13.5.5.3 Product footprint 214 13.5.5.4 Purchase type footprint 214 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 215 13.6.1 PROGRESSIVE COMPANIES 215 13.6.2 RESPONSIVE COMPANIES 215 13.6.3 DYNAMIC COMPANIES 215 13.6.4 STARTING BLOCKS 215 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 217 13.6.5.1 Detailed list of key startups/SMEs 217 13.6.5.2 Competitive benchmarking of key startups/SMEs 217 13.7 COMPANY VALUATION AND FINANCIAL METRICS 218 13.7.1 COMPANY VALUATION 218 13.7.2 FINANCIAL METRICS 219 13.8 BRAND/PRODUCT COMPARISON 220 13.9 COMPETITIVE SCENARIO 221 13.9.1 PRODUCT LAUNCHES & APPROVALS 221 13.9.2 DEALS 222 13.9.3 EXPANSIONS 223 13.9.4 OTHER DEVELOPMENTS 224 14 COMPANY PROFILES 225 14.1 KEY PLAYERS 225 14.1.1 SOMNOMED 225 14.1.1.1 Business overview 225 14.1.1.2 Products offered 226 14.1.1.3 MnM view 227 14.1.1.3.1 Key strengths 227 14.1.1.3.2 Strategic choices 227 14.1.1.3.3 Weaknesses & competitive threats 227 14.1.2 RESMED 228 14.1.2.1 Business overview 228 14.1.2.2 Products offered 229 14.1.2.2.1 Deals 230 14.1.2.2.2 Expansions 230 14.1.2.3 MnM view 230 14.1.2.3.1 Key strengths 230 14.1.2.3.2 Strategic choices 231 14.1.2.3.3 Weaknesses & competitive threats 231 14.1.3 PROSOMNUS SLEEP TECHNOLOGIES 232 14.1.3.1 Business overview 232 14.1.3.2 Products offered 233 14.1.3.3 Recent developments 233 14.1.3.3.1 Deals 233 14.1.3.4 MnM view 233 14.1.3.4.1 Key strengths 233 14.1.3.4.2 Strategic choices 233 14.1.3.4.3 Weaknesses & competitive threats 234 14.1.4 DYNAFLEX 235 14.1.4.1 Business overview 235 14.1.4.2 Products offered 235 14.1.4.3 Recent developments 236 14.1.4.3.1 Deals 236 14.1.5 VIVOS THERAPEUTICS, INC. 237 14.1.5.1 Business overview 237 14.1.5.2 Products offered 238 14.1.5.3 Recent developments 238 14.1.5.3.1 Product approvals 238 14.1.5.3.2 Deals 239 14.1.5.3.3 Expansions 239 14.1.5.3.4 Other developments 240 14.1.6 OPENAIRWAY 241 14.1.6.1 Business overview 241 14.1.6.2 Products offered 241 14.1.6.3 Recent developments 241 14.1.6.3.1 Deals 241 14.1.7 PANTHERA DENTAL 242 14.1.7.1 Business overview 242 14.1.7.2 Products offered 242 14.1.7.3 Recent developments 243 14.1.7.3.1 Product launches 243 14.1.7.3.2 Deals 243 14.1.7.3.3 Other developments 243 14.1.8 AIRWAY MANAGEMENT 244 14.1.8.1 Business overview 244 14.1.8.2 Products offered 244 14.1.8.3 Recent developments 244 14.1.8.3.1 Product launches 244 14.1.9 APNEA SCIENCES 245 14.1.9.1 Business overview 245 14.1.9.2 Products offered 245 14.1.10 ORAVANOSA 246 14.1.10.1 Business overview 246 14.1.10.2 Products offered 246 14.1.11 MYERSON LLC. 247 14.1.11.1 Business overview 247 14.1.11.2 Products offered 247 14.1.12 BRAEBON MEDICAL CORPORATION 248 14.1.12.1 Business overview 248 14.1.12.2 Products offered 248 14.2 OTHER PLAYERS 249 14.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS 249 14.2.2 THE SNORE RELIEVER COMPANY, LLC 249 14.2.3 TOMED GMBH 250 14.2.4 THE AURUM GROUP 250 14.2.5 ERKODENT ENRICH KOPP GMBH 251 14.2.6 OSCIMED SA 251 14.2.7 SICAT GMBH & CO. KG 252 14.2.8 GLIDEWELL 252 14.2.9 APNOMED, INC. 253 14.2.10 ZQUIET 254 14.2.11 DREAM SYSTEMS DENTAL SLEEP LAB 254 14.2.12 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC 255 14.2.13 ORTHOAPNEA 255 14.2.14 DOC BRANDS, INC. 256 15 APPENDIX 257 15.1 DISCUSSION GUIDE 257 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 261 15.3 CUSTOMIZATION OPTIONS 263 15.4 RELATED REPORTS 263 15.5 AUTHOR DETAILS 264
圖表清單 List of Tables & Figures
TABLE 1 SLEEP APNEA ORAL APPLIANCES MARKET: INCLUSIONS & EXCLUSIONS 29 TABLE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RISK ASSESSMENT ANALYSIS 45 TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022−2024 55 TABLE 4 SUPPORTIVE AWARENESS INITIATIVES FOR EFFECTS OF UNTREATED SLEEP APNEA 56 TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA 57 TABLE 6 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023−2025 (USD) 63 TABLE 7 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023−2025 63 TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023−2025 (USD) 64 TABLE 9 SLEEP APNEA ORAL APPLIANCES MARKET: ROLE IN ECOSYSTEM 67 TABLE 10 SLEEP APNEA ORAL APPLIANCES MARKET: PORTER’S FIVE FORCES ANALYSIS 68 TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71 TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72 TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 73 TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 20 IMPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES, BY COUNTRY, 2020–2024 (USD MILLION) 79 TABLE 21 EXPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES, BY COUNTRY, 2020–2024 (USD MILLION) 79 TABLE 22 SLEEP APNEA ORAL APPLIANCES MARKET: KEY CONFERENCES & EVENTS, 2025−2026 81 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES, BY END USERS (%) 83 TABLE 24 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 84 TABLE 25 SLEEP APNEA ORAL APPLIANCES MARKET: END-USER ANALYSIS 88 TABLE 26 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT FEATURES AND COMPARATIVE ASSESSMENT 91 TABLE 27 SLEEP APNEA ORAL APPLIANCES MARKET: NEED GAP ANALYSIS 92 TABLE 28 US ADJUSTED RECIPROCAL TARIFF RATES 93 TABLE 29 ORAL APPLIANCES OFFERED BY KEY PLAYERS 95 TABLE 30 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 96 TABLE 31 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 96 TABLE 32 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 97 TABLE 33 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 97 TABLE 34 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 35 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 36 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 37 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 99 TABLE 38 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 99 TABLE 39 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 100 TABLE 40 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 100 TABLE 41 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 100 TABLE 42 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 101 TABLE 43 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 101 TABLE 44 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 102 TABLE 45 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 102 TABLE 46 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 102 TABLE 47 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS 103 TABLE 48 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 103 TABLE 49 NORTH AMERICA: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 50 EUROPE: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 51 ASIA PACIFIC: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 52 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2022–2030 (USD MILLION) 105 TABLE 53 NORTH AMERICA: DAYTIME-NIGHTTIME APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 105 TABLE 54 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 107 TABLE 55 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES OFFERED BY KEY PLAYERS 108 TABLE 56 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY REGION, 2022–2030 (USD MILLION) 108 TABLE 57 NORTH AMERICA: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109 TABLE 58 EUROPE: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109 TABLE 59 ASIA PACIFIC: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109 TABLE 60 ONLINE OTC ORAL APPLIANCES OFFERED BY KEY PLAYERS 110 TABLE 61 ONLINE OTC ORAL APPLIANCES MARKET, BY REGION, 2022–2030 (USD MILLION) 110 TABLE 62 NORTH AMERICA: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111 TABLE 63 EUROPE: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111 TABLE 64 ASIA PACIFIC: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111 TABLE 65 PREVALENCE OF SLEEP APNEA, BY AGE GROUP & GENDER 113 TABLE 66 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 113 TABLE 67 SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 114 TABLE 68 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 114 TABLE 69 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 115 TABLE 70 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 115 TABLE 71 SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 116 TABLE 72 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 73 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 117 TABLE 74 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 117 TABLE 75 PREVALENCE OF SLEEP APNEA, BY AGE GROUP, 2021 119 TABLE 76 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 119 TABLE 77 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY REGION, 2022–2030 (USD MILLION) 120 TABLE 78 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 120 TABLE 79 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 121 TABLE 80 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 121 TABLE 81 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY REGION, 2022–2030 (USD MILLION) 122 TABLE 82 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 122 TABLE 83 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 123 TABLE 84 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 123 TABLE 85 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY REGION, 2022–2030 (USD MILLION) 124 TABLE 86 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 124 TABLE 87 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 125 TABLE 88 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 125 TABLE 89 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 127 TABLE 90 SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY REGION, 2022–2030 (USD MILLION) 128 TABLE 91 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 128 TABLE 92 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 129 TABLE 93 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 129 TABLE 94 SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022–2030 (USD MILLION) 130 TABLE 95 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 130 TABLE 96 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 131 TABLE 97 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 131 TABLE 98 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY REGION, 2022–2030 (USD MILLION) 132 TABLE 99 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 132 TABLE 100 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 133 TABLE 101 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 133 TABLE 102 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 135 TABLE 103 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2022–2030 (USD MILLION) 136 TABLE 104 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022–2030 (USD MILLION) 136 TABLE 105 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022–2030 (USD MILLION) 137 TABLE 106 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022–2030 (USD MILLION) 137 TABLE 107 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION) 138 TABLE 108 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 139 TABLE 109 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 139 TABLE 110 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 139 TABLE 111 SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY REGION, 2022–2030 (USD MILLION) 140 TABLE 112 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 140 TABLE 113 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 141 TABLE 114 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 141 TABLE 115 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2022–2030 (USD MILLION) 143 TABLE 116 NORTH AMERICA: MACROECONOMIC INDICATORS 144 TABLE 117 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 145 TABLE 118 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (THOUSAND UNITS) 146 TABLE 119 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 146 TABLE 120 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 146 TABLE 121 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 147 TABLE 122 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 147 TABLE 123 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 147 TABLE 124 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 148 TABLE 125 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 148 TABLE 126 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN US 149 TABLE 127 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 150 TABLE 128 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 150 TABLE 129 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 150 TABLE 130 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 151 TABLE 131 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 151 TABLE 132 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 151 TABLE 133 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 152 TABLE 134 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN CANADA 153 TABLE 135 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 153 TABLE 136 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 153 TABLE 137 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 154 TABLE 138 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 154 TABLE 139 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 154 TABLE 140 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 155 TABLE 141 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 155 TABLE 142 EUROPE: MACROECONOMIC INDICATORS 156 TABLE 143 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 156 TABLE 144 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 157 TABLE 145 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 157 TABLE 146 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 157 TABLE 147 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 158 TABLE 148 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 158 TABLE 149 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 158 TABLE 150 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 159 TABLE 151 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN GERMANY 160 TABLE 152 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 160 TABLE 153 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 160 TABLE 154 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 161 TABLE 155 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 161 TABLE 156 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 161 TABLE 157 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 162 TABLE 158 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 162 TABLE 159 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 163 TABLE 160 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 163 TABLE 161 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 164 TABLE 162 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 164 TABLE 163 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 164 TABLE 164 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 165 TABLE 165 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 165 TABLE 166 LEADING MARKET PLAYERS & PRODUCTS REIMBURSED BY SOCIAL SECURITY OF FRANCE 166 TABLE 167 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 166 TABLE 168 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 166 TABLE 169 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 167 TABLE 170 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 167 TABLE 171 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 167 TABLE 172 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 168 TABLE 173 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 168 TABLE 174 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 169 TABLE 175 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 169 TABLE 176 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 169 TABLE 177 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 170 TABLE 178 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 170 TABLE 179 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 170 TABLE 180 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 171 TABLE 181 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 172 TABLE 182 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 172 TABLE 183 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 172 TABLE 184 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 173 TABLE 185 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 173 TABLE 186 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 173 TABLE 187 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 174 TABLE 188 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 174 TABLE 189 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 175 TABLE 190 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 175 TABLE 191 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 175 TABLE 192 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 176 TABLE 193 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 176 TABLE 194 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 176 TABLE 195 ASIA PACIFIC: MACROECONOMIC INDICATORS 177 TABLE 196 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 179 TABLE 197 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 179 TABLE 198 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 179 TABLE 199 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 180 TABLE 200 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 180 TABLE 201 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 180 TABLE 202 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 181 TABLE 203 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 181 TABLE 204 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 182 TABLE 205 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 182 TABLE 206 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 183 TABLE 207 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 183 TABLE 208 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 183 TABLE 209 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 184 TABLE 210 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 184 TABLE 211 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 185 TABLE 212 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 185 TABLE 213 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 185 TABLE 214 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 186 TABLE 215 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 186 TABLE 216 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 186 TABLE 217 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 187 TABLE 218 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 188 TABLE 219 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 188 TABLE 220 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 188 TABLE 221 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 189 TABLE 222 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 189 TABLE 223 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 189 TABLE 224 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 190 TABLE 225 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 191 TABLE 226 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 191 TABLE 227 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 191 TABLE 228 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 192 TABLE 229 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 192 TABLE 230 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 192 TABLE 231 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 193 TABLE 232 LATIN AMERICA: MACROECONOMIC INDICATORS 194 TABLE 233 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 194 TABLE 234 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 195 TABLE 235 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 195 TABLE 236 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 195 TABLE 237 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 196 TABLE 238 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 196 TABLE 239 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 196 TABLE 240 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 197 TABLE 241 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 198 TABLE 242 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 198 TABLE 243 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 198 TABLE 244 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 199 TABLE 245 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 199 TABLE 246 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 199 TABLE 247 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 200 TABLE 248 GCC COUNTRIES: MACROECONOMIC INDICATORS 201 TABLE 249 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 201 TABLE 250 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 202 TABLE 251 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 202 TABLE 252 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 202 TABLE 253 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 203 TABLE 254 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 203 TABLE 255 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 203 TABLE 256 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET 204 TABLE 257 SLEEP APNEA ORAL APPLIANCES MARKET: DEGREE OF COMPETITION 208 TABLE 258 SLEEP APNEA ORAL APPLIANCES MARKET: REGION FOOTPRINT 213 TABLE 259 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT FOOTPRINT 214 TABLE 260 SLEEP APNEA ORAL APPLIANCES MARKET: PURCHASE TYPE FOOTPRINT 214 TABLE 261 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 217 TABLE 262 SLEEP APNEA ORAL APPLIANCES MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 217 TABLE 263 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 221 TABLE 264 SLEEP APNEA ORAL APPLIANCES MARKET: DEALS, JANUARY 2021–APRIL 2025 222 TABLE 265 SLEEP APNEA ORAL APPLIANCES MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025 223 TABLE 266 SLEEP APNEA ORAL APPLIANCES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 224 TABLE 267 SOMNOMED: COMPANY OVERVIEW 225 TABLE 268 SOMNOMED: PRODUCTS OFFERED 226 TABLE 269 RESMED: COMPANY OVERVIEW 228 TABLE 270 RESMED: PRODUCTS OFFERED 229 TABLE 271 RESMED: DEALS, JANUARY 2021–APRIL 2025 230 TABLE 272 RESMED: EXPANSIONS, JANUARY 2021–APRIL 2025 230 TABLE 273 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW 232 TABLE 274 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED 233 TABLE 275 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–APRIL 2025 233 TABLE 276 DYNAFLEX: COMPANY OVERVIEW 235 TABLE 277 DYNAFLEX: PRODUCTS OFFERED 235 TABLE 278 DYNAFLEX: DEALS, JANUARY 2021–APRIL 2025 236 TABLE 279 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW 237 TABLE 280 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED 238 TABLE 281 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–APRIL 2025 238 TABLE 282 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–APRIL 2025 239 TABLE 283 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–APRIL 2025 239 TABLE 284 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 240 TABLE 285 OPENAIRWAY: COMPANY OVERVIEW 241 TABLE 286 OPENAIRWAY: PRODUCTS OFFERED 241 TABLE 287 OPENAIRWAY: DEALS, JANUARY 2021–APRIL 2025 241 TABLE 288 PANTHERA DENTAL: COMPANY OVERVIEW 242 TABLE 289 PANTHERA DENTAL: PRODUCTS OFFERED 242 TABLE 290 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 243 TABLE 291 PANTHERA DENTAL: DEALS, JANUARY 2021–APRIL 2025 243 TABLE 292 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 243 TABLE 293 AIRWAY MANAGEMENT: COMPANY OVERVIEW 244 TABLE 294 AIRWAY MANAGEMENT: PRODUCTS OFFERED 244 TABLE 295 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 244 TABLE 296 APNEA SCIENCES: COMPANY OVERVIEW 245 TABLE 297 APNEA SCIENCES: PRODUCTS OFFERED 245 TABLE 298 ORAVANOSA: COMPANY OVERVIEW 246 TABLE 299 ORAVANOSA: PRODUCTS OFFERED 246 TABLE 300 MYERSON LLC.: COMPANY OVERVIEW 247 TABLE 301 MYERSON LLC.: PRODUCTS OFFERED 247 TABLE 302 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW 248 TABLE 303 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED 248 TABLE 304 MPOWRX HEALTH & WELLNESS PRODUCTS: COMPANY OVERVIEW 249 TABLE 305 THE SNORE RELIEVER COMPANY, LLC.: COMPANY OVERVIEW 249 TABLE 306 TOMED GMBH: COMPANY OVERVIEW 250 TABLE 307 THE AURUM GROUP: COMPANY OVERVIEW 250 TABLE 308 ERKODENT ENRICH KOPP GMBH: COMPANY OVERVIEW 251 TABLE 309 OSCIMED SA: COMPANY OVERVIEW 251 TABLE 310 SICAT GMBH & CO.KG: COMPANY OVERVIEW 252 TABLE 311 GLIDEWELL: COMPANY OVERVIEW 252 TABLE 312 APNOMED, INC.: COMPANY OVERVIEW 253 TABLE 313 ZQUIET: COMPANY OVERVIEW 254 TABLE 314 DREAM SYTEMS DENTAL SLEEP LAB: COMPANY OVERVIEW 254 TABLE 315 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC: COMPANY OVERVIEW 255 TABLE 316 ORTHOAPNEA: COMPANY OVERVIEW 255 TABLE 317 DOC BRANDS, INC.: COMPANY OVERVIEW 256 FIGURE 1 MARKETS & REGIONS COVERED 30 FIGURE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RESEARCH DESIGN 32 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 39 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40 FIGURE 6 SLEEP APNEA ORAL APPLIANCES MARKET: TOP-DOWN APPROACH 41 FIGURE 7 DATA TRIANGULATION METHODOLOGY 42 FIGURE 8 SLEEP APNEA ORAL APPLIANCES MARKET: IMPACT ANALYSIS 44 FIGURE 9 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 46 FIGURE 10 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2025 VS. 2030 (USD MILLION) 47 FIGURE 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2025 VS. 2030 (USD MILLION) 47 FIGURE 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2025 VS. 2030 (USD MILLION) 48 FIGURE 13 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2025 VS. 2030 (USD MILLION) 49 FIGURE 14 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 49 FIGURE 15 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 50 FIGURE 16 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET 51 FIGURE 17 MANDIBULAR ADVANCEMENT DEVICES SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 52 FIGURE 18 MANDIBULAR ADVANCEMENT DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US IN 2024 53 FIGURE 19 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 53 FIGURE 20 SLEEP APNEA ORAL APPLIANCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54 FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING & ASSEMBLY PHASES 65 FIGURE 22 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES 66 FIGURE 23 SLEEP APNEA ORAL APPLIANCES MARKET: ECOSYSTEM ANALYSIS 67 FIGURE 24 SLEEP APNEA ORAL APPLIANCES MARKET: PORTER’S FIVE FORCES ANALYSIS 68 FIGURE 25 SLEEP APNEA ORAL APPLIANCES MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2023 80 FIGURE 26 SLEEP APNEA ORAL APPLIANCES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES 83 FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 84 FIGURE 29 AI USE CASES 86 FIGURE 30 SLEEP APNEA ORAL APPLIANCES MARKET: INVESTMENT & FUNDING SCENARIO 2019−2024 87 FIGURE 31 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 145 FIGURE 32 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 178 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET, 2022−2024 (USD MILLION) 207 FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET (2024) 208 FIGURE 35 RANKING OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET, 2024 209 FIGURE 36 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 211 FIGURE 37 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY FOOTPRINT 212 FIGURE 38 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024 216 FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 218 FIGURE 40 EV/EBITDA OF KEY VENDORS 219 FIGURE 41 SLEEP APNEA ORAL APPLIANCES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 220 FIGURE 42 SOMNOMED: COMPANY SNAPSHOT (2024) 226 FIGURE 43 RESMED: COMPANY SNAPSHOT (2023) 229 FIGURE 44 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023) 232 FIGURE 45 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024) 237

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們